Barclays’s Akcea Therapeutics Inc AKCA Stock Holding History

Barclays’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-128,800	Closed	-$4.51M	–	7591
2018 Q3	$4.51M	Buy	+128,800	New	+$3.9M	﹤0.01%	1916

Barclays's AKCA Position: Q4 2020 in Review

Barclays sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 38,334 shares — an estimated $696K sold.

Barclays first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $696K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Barclays reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Barclays sold 38,334 Akcea Therapeutics Inc shares in Q4 2020, an estimated $696K.
Barclays first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
Barclays's Akcea Therapeutics Inc position peaked at $696K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Barclays's 13F filing for Q4 2020, filed 11 Feb 2021.